1. Medtech Insight
  2. >>Policy & Regulation
  3. >>Regulation

Study Progress Updated To ‘Ongoing’: FDA Publishes Interim Report Three Years Into Essure Study

 
• By Hannah Daniel

In a report on Bayer’s postmarket study of Essure, the FDA says Bayer’s study is back on track with its five-year plan.

• Source: Shutterstock

Bayer’s postmarket study of Essure is back on track after a sharp drop in participants in October 2022, the US Food and Drug Administration said in a three-year interim update.

Essure, a sterilization implant marketed by Bayer, was recalled in 2018 in the US. By the end of 2019, all unused devices were removed from the market

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

More from Policy & Regulation

Tariffs Threaten Medtech Innovation And US Position As World Leader, Whitaker Tells Lawmakers

 
• By Brian Bossetta

During his testimony before US senators on the impact of tariffs on critical supply chains, AdvaMed’s Scott Whitaker said the Trump tariffs could jeopardize America’s preeminence in medtech. Other industry experts echoed similar concerns.

Califf Warns Progress May Be In Danger Due To ‘Decimated’ FDA Staff

 
• By Barnaby Pickering

In Vivo spoke to the previous commissioner of the US FDA about recent ongoings at the agency, and where he believes policy should be directed for patient and industry benefit.

What’s A Diagnostic? WHO Wants To Know

 
• By Elizabeth Orr

The World Health Organization is seeking input from stakeholders to create an official definition of the term ‘diagnostics.’ This initiative follows a 2023 resolution aimed at enhancing global diagnostics capacity; the definition, it is hoped, will help drive the creation of effective health policies. Comments will be accepted until 23 May.